Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
Study Title
- Open-Label Assessment of the Albuterol Spiromaxֲ® Dry Powder Inhaler (DPI)
Teva Identifier
- ABS-AS-308
ClinicalTrials.gov Identifier
- NCT01857323
Study Status
- Completed
Trial Condition(s)
- Asthma | Chronic Obstructive Pulmonary Disease (COPD)
Interventions
- Drug: Albuterol Spiromaxֲ®
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years and older
Trial Duration
- 05/01/2013 - 09/01/2013
Phase
- Phase 3
Study Type
Interventional
